Citation Impact
Citing Papers
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Prevalence and risk of violence against children with disabilities: a systematic review and meta-analysis of observational studies
2012 Standout
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents
2007
Mirtazapine Orally Disintegrating Tablets Versus Venlafaxine Extended Release
2006
Does Study Design Influence Outcome?
2009
Striatal dopamine transporter density in major depression
1999
Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.
2017 Standout
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
2018 Standout
Prevention of Major Depression
2010
Depression
2018 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
2006 Standout
Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial
2005
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
2006
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
Functional Neuroimaging of Anxiety: A Meta-Analysis of Emotional Processing in PTSD, Social Anxiety Disorder, and Specific Phobia
2007 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Prenatal and postnatal exposure to bisphenol a induces anxiolytic behaviors and cognitive deficits in mice
2010
Pharmacokinetics of selective serotonin reuptake inhibitors
2000
Targeting Interleukin-6 Signaling in Clinic
2019
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and α1-adrenergic receptor
2009
Syndemics and the biosocial conception of health
2017 Standout
Dietary Intake and Bioavailability of Polyphenols
2000 Standout
Schizophrenia
2009 Standout
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
2011
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Notch signaling in development and disease
2003
Venlafaxine versus Mirtazapine in the??Treatment of Undifferentiated Somatoform Disorder
2008
Aggressive behaviour, victimisation and crime among severely mentally ill patients requiring hospitalisation
2007
Genetic Polymorphisms of HumanN-Acetyltransferase, Cytochrome P450, Glutathione-S-Transferase, and Epoxide Hydrolase Enzymes: Relevance to Xenobiotic Metabolism and Toxicity
1999
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Itching for Insight
2009 StandoutNobel
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Mirtazapine Orally Disintegrating Tablet Versus Sertraline: A Prospective Onset of Action Study
2003
Latency to first seizure after temporal lobectomy predicts long‐term outcome
2010
The neuronal insulin sensitizer dicholine succinate reduces stress-induced depressive traits and memory deficit: possible role of insulin-like growth factor 2
2012
The pharmacology of putative early-onset antidepressant strategies
2003
Comparison of the Effects of Mirtazapine and Fluoxetine in Severely Depressed Patients
2005
Optimal Dosing of Atypical Antipsychotics in Adults: A Review of the Current Evidence
2002
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
2011 StandoutNature
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Measuring inconsistency in meta-analyses
2003 Standout
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
Brain-Derived Neurotrophic Factor Val66Met and Psychiatric Disorders: Meta-Analysis of Case-Control Studies Confirm Association to Substance-Related Disorders, Eating Disorders, and Schizophrenia
2007
Depression as a Microglial Disease
2015
The Neurocircuitry of Fear, Stress, and Anxiety Disorders
2009
Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evidence-Based Findings from Post Hoc Analysis of Three Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Studies
2007
Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior
2010 StandoutNobel
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
The Neural Correlates of Social Anxiety Disorder and Response to Pharmacotherapy
2006
Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine
2010 StandoutNobel
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
2006 Standout
Neuroimaging Studies of Amygdala Function in Anxiety Disorders
2003
The Adolescent Brain
2008 Standout
Major Depressive Disorder
2008 Standout
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
2010 Standout
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications
2015
Enantiomers' potential in psychopharmacology—a critical analysis with special emphasis on the antidepressant escitalopram
2002
Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia
2007
Mirtazapine Versus Venlafaxine in Hospitalized Severely Depressed Patients With Melancholic Features
2001
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
2007 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
The molecular neurobiology of depression
2008 StandoutNature
Psychopharmacologic Treatment of Depression in the Medically Ill
1998
The integration of negative affect, pain and cognitive control in the cingulate cortex
2011 Standout
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
1996
HPA axis response to a psychological stressor in generalised social phobia
2002
Clinically Significant Drug Interactions with Newer Antidepressants
2011
The neurobiology of itch
2006
Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity
1997
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
The neurobiology of depression and antidepressant action
2012
Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians
2008
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
2002
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
2006
Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress
2006 StandoutScience
Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression
2000
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
ILAE Official Report: A practical clinical definition of epilepsy
2014 Standout
Cytokine Storm
2020 Standout
Selective serotonin reuptake inhibitors in affective disorders — I. Basic pharmacology
1998
How antipsychotics work—From receptors to reality
2006
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
2000 Standout
Applications of Clinical Dopamine Imaging
2006
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of Esa Leìnonen being referenced
Fluvoxamine increases the clozapine serum levels significantly
1996
Increase in Plasma Proinflammatory Cytokines After Electroconvulsive Therapy in Patients With Depressive Disorder
2008
Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression
2010
Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy
2008
Attitudes towards neuroleptic treatment: Reliability and validity of the Attitudes towards Neuroleptic Treatment (ANT) questionnaire
2000
A Review of the Pharmacological and Clinical Profile of Mirtazapine
2001
Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine
2014
Double-blind study of mirtazapine and placebo in hospitalized patients with major depression
1994
Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression
2007
Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder
1999
A 12‐week double‐blind multi‐centre study of paroxetine and imipramine in hospitalized depressed patients
1994
Clozapine Serum Concentrations are Lower in Smoking than in Non‐Smoking Schizophrenic Patients
1999
Substituting Carbamazepine with Oxcarbazepine Increases Citalopram Levels. A Report on Two Cases
2007
Catechol-O-methyltransferase and Monoamine Oxidase A Genotypes and Drug Response to Conventional Neuroleptics in Schizophrenia
2003
NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia
2003
Long‐term efficacy and safety of milnacipran compared to clomipramine in patients with major depression
1997
Postoperative EEG and Electrocorticography: Relation to Clinical Outcome in Patients with Temporal Lobe Surgery
1994
A Controlled, Prospective, 1-Year Trial of Citalopram in the Treatment of Panic Disorder
1998
The comparison of burden between caregiving spouses of depressive and demented patients
2001
Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics
2004
Association of EGF polymorphism with schizophrenia in Finnish men
2004
Debrisoquine Hydroxylation Phenotypes of
1992
2003
Debrisoquine hydroxylation phenotypes of patients with high versus low to normal serum antidepressant concentrations.
1992
Letters
1993
Dopamine reuptake site densities in patients with social phobia
1997
Fluvoxamine Augmentation Increases Serum Mirtazapine Concentrations Three- to Fourfold
2001
Paroxetine increases serum trimipramine concentration. A report of two cases
1995